Peptide and Anticoagulant Drug Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2028
The peptide and anticoagulant drugs market is projected to register a CAGR of 3.3% during the forecast period (2022-2028). Peptides are a chain of amino acids. Anticoagulants are blood thinners that prevent coagulation of blood, prolonging the clotting time. The peptide and anticoagulant drugs are used for myocardial infarction, pulmonary embolism, stroke, and others. Increasing healthcare expenditure is one of the driving factors in boosting the growth of the peptide and anticoagulant drug market. For instance, according to the data published by the Centre for Medicare and Medicaid Services (CMS), the US health expenditure grew by $9.7 to $4.1 trillion in 2020 and accounted for 19.1% of Gross Domestic Product (GDP). Similarly, Medicare spending grew by 3.5% to $829.1 billion in 2020 which is 20 % of total national health expenditure. Whereas, Medicaid spending grew by 9.2% to $671.2 billion in 2020, which is 16 % of total national health expenditure. Moreover, according to CMS, national health spending is anticipated to grow at an average annual rate of 5.4 % and to reach $6.2 trillion by 2028.
To Request a Sample of our Report on Peptide
and Anticoagulant Drug Market: https://www.omrglobal.com/request-sample/peptide-and-anticoagulant-market
The global peptide and anticoagulant
drug market are segmented based on product and application. Based on the
product, the market is further sub-segmented into Hormonal, antibiotic,
antifungal, ACE inhibitor, others. Based on application, the market is
sub-segmented into diabetes, cancer, osteoporosis, cardiology, gynecology,
infectious diseases, others. Among these, the antibiotics segment is expected
to hold a considerable share in the market during the forecast period owing to
an incline in bacterial infections.
(Get 15% Discount on Buying this Report)
A
full Report of Peptide and Anticoagulant Drug Market is Available @ https://www.omrglobal.com/industry-reports/peptide-and-anticoagulant-market
Global Peptide and anticoagulant drug Market Segmentation
By Product
·
Antibiotics
·
Antifungal
·
ACE Inhibitor
·
Hormonal
By application
·
Cardiology
·
Gynecology
·
Diabetes
·
Cancer
·
Osteoporosis
·
Infectious Diseases
Regional
Analysis
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Company Profiles
·
Amgen,Inc
·
Aspen Pharmacare Holdings, Ltd.
·
AmbioPharm,Inc.
·
Boehringer Ingelheim International GmbH
·
Bristol-Myers Squibb Co.
·
Biofera Laboratories Pvt Ltd.
·
BACHEM AG
·
Daiichi Sankyo Co.
·
EVER Pharma
·
Dr.Reddys Laboratories , Ltd.
·
LEO Pharma A/S
·
SANOFI
·
Novartis AG
·
Novo Nordisk A/S
·
Takeda Pharmacuetical Co ,Ltd.
·
Teva Pharmaceutical Industries
·
Wockhardt Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment